Geo Group Approved for REIT Status and 4 Stocks Hitting 52-Week Highs

Biomarin Pharmaceuticals (NASDAQ:BMRN): Closing price $54.08

BioMarin’s Achondroplasia treatment wins FDA Orphan Drug designation. Shares closed up 0.97 percent on the day at$54.08, and have traded in a 52-week range of $31.91 to $53.84.

bio